UCLA receives $29million gift to build new centre for Precision Genomic Medicine
The Dr. Allen and Charlotte Ginsburg Center for Precision Genomic Medicine will enable scientists to leverage big data and genomic technologies…
February 2021
Prof. Ingemar Ernberg, discusses the differences between EBV research and Coronavirus Research
Prof Dr Ingemar Ernberg, Professor at Karolinska Institutet, joined us on February 11, 2021
Zoe Martin, speaks about the lag phase effects of Cancer Research funding in the UK due to COVID-19
Zoe Martin, Policy Manager, of Cancer Research UK, joined our panel discussion on February 11, 2021
Dr Sheuli Porkess, speaks about how advancements in AI have facilitated cancer research during the pandemic
Dr. Sheuli Porkess, Interim Medical Director, of The Association of the British Pharmaceutical Industry (ABPI) joined us on February 11, 2021
Begonya Nafria Escalera
Patient Engagement in Research Coordinator at Sant Joan de Déu Chidren’s Hospital (Spain)
Dr Euan Ashley BSc
Euan Ashley BSc, MB ChB, FRCP, DPhil, FAHA, FACC, Professor of Medicine & Genetics, Associate Dean, Precision Health, Stanford University.
Chris Carrigan
Chris Carrigan is a specialist in health data and information, but with a particular focus on patient involvement and patient power.
The European Commission announces its ‘Europe’s Beating Cancer Plan
On February 3rd, The European Commission unveiled its ‘Europe’s Beating Cancer Plan’ that sets out a new EU approach to cancer treatment
Discovery of High Levels of Specific Gene Involved in Breast Cancer Growth Could Lead to New Precision Medicine Therapies
A study done by researchers at UT Southerwestern (UTSW) has found that a significant amount of breast cancer patients have higher levels of the ZMYND8 gene
Rita Magenheim MD
Rita Magenheim MD is a patient representative in the ERN-GENTURIS, the European organisation for hereditary cancer syndrome.